Bicycle Therapeutics (BCYC) Cash from Operations (2018 - 2025)
Historic Cash from Operations for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$71.2 million.
- Bicycle Therapeutics' Cash from Operations fell 7868.3% to -$71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$239.7 million, marking a year-over-year decrease of 1831.49%. This contributed to the annual value of -$164.7 million for FY2024, which is 17169.62% down from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Cash from Operations is -$71.2 million, which was down 7868.3% from -$72.8 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Cash from Operations registered a high of $34.1 million during Q2 2023, and its lowest value of -$86.4 million during Q1 2025.
- Over the past 5 years, Bicycle Therapeutics' median Cash from Operations value was -$26.4 million (recorded in 2022), while the average stood at -$29.3 million.
- Its Cash from Operations has fluctuated over the past 5 years, first surged by 31750.63% in 2021, then crashed by 378604.88% in 2024.
- Bicycle Therapeutics' Cash from Operations (Quarter) stood at -$10.4 million in 2021, then plummeted by 190.46% to -$30.3 million in 2022, then tumbled by 56.02% to -$47.3 million in 2023, then surged by 80.13% to -$9.4 million in 2024, then crashed by 657.48% to -$71.2 million in 2025.
- Its Cash from Operations was -$71.2 million in Q3 2025, compared to -$72.8 million in Q2 2025 and -$86.4 million in Q1 2025.